Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy Volunteers

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

Donald J. Schuirmann · Journal of Pharmacokinetics and Biopharmaceutics · 1987 · 2.5K citations · Full text

Average Bioavailability, Health Outcome, Bioequivalence +8

Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) [RETIRED]

Stephen D. Silberstein · Neurology · 2000 · 1.4K citations · Full text

Evidence-based Therapy, Evidence-based Guidelines, Pain Medicine +9

Migraine Diagnosis and Treatment: Results From the American Migraine Study II

Richard B. Lipton, Seymour Diamond, Michael L. Reed et al. · Headache The Journal of Head and Face Pain · 2001 · 721 citations

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

Ángel Lanas, Luis A. Garcı́a Rodrı́guez, M Arroyo et al. · Gut · 2006 · 517 citations · Full text

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis

Loren Laine, S. E. Harper, Thomas Simon et al. · Gastroenterology · 1999 · 476 citations

Anti-inflammatory, Gastrointestinal Pharmacology, Cyclooxygenase 2–Specific +9